Vanderbilt-Shanghai Chronic Disease Research Training Program

中国的经济快速发展、现代化和西式生活方式一直在 伴随着慢性病疫情的出现。因此，心血管疾病和 在中国的大多数城市，癌症已经取代传染病成为主要的死亡原因。这个 随着中国人口老龄化，慢性病负担预计将继续增加。这个 范德比尔特医学和公共卫生研究所和范德比尔特全球卫生研究所是 与上海预防医学研究院(SIPM)、复旦大学和 上海肿瘤研究所(SCI)将建立范德比尔特-上海慢性病研究培训 项目(VU-Shanghai CDRTP)。CDRTP的具体目标是：(1)培养一支专家队伍，以 开展多学科慢性病研究，建设中国培训能力；(2)培养一名新的 一代科学家和未来慢性病研究的领军人物中国；(3)建设科研 中国的能力，并与范德比尔特慢性病建立长期合作关系 研究人员；(4)确保和记录中国培训项目的长期成功，这些培训项目包括 通过该奖项促进和升级；(5)在慢性疾病方面建立国家和国际领导地位 通过现有和新建立的网络进行疾病预防和控制。培训计划 包括学者培训(范德比尔特大学3个月)、研究生培训(1-2年的教学课程工作 复旦大学，为期3个月的SIPM或SCI研究实践，以及1年的论文研究 (范德比尔特)、两个为期五天的国内讲习班和一次国际会议。培训的重点将是 先进的流行病学和生物统计学方法，设计和执行多学科研究 项目，建立癌症、心血管疾病和糖尿病研究方面的专业知识，以及赠款 写作技巧。VU-Shanghai CDRTP，建立在现有研究和培训的基础上 项目和参与机构之间的长期合作，将产生重要的和 长期影响中国对慢性病的研究和预防。 相关性(请参阅说明)： 慢性病正在成为中国的主要健康负担。范德比尔特将与公共卫生合作 上海领导培训慢性病研究专家干部和下一代研究人员， 建设研究能力和本地培训设施。这项计划将对 中国的慢性病研究和预防，并可能推广到其他发展中国家。

The rapid economic development, modernization and adoption of a Western lifestyle in China have been accompanied by the emergence of chronic disease epidemics. As a result, cardiovascular disease and cancer have now replaced infectious diseases as the leading causes of death in most cities in China. The burden of chronic disease is expected to continue increasing as the Chinese population ages. The Vanderbilt Institute for Medicine and Public Health and the Vanderbilt Institute for Global Health are partnering with the Shanghai Institutes of Preventive Medicine (SIPM), Fudan University, and the Shanghai Cancer Institute (SCI) to establish the Vanderbilt-Shanghai Chronic Disease Research Training Program (VU-Shanghai CDRTP). The specific aims of the CDRTP are: (1) to train a cadre of experts to conduct multi-disciplinary chronic disease research and build training capacity in China; (2). to train a new generation of scientists and future leaders in chronic diseases research in China; (3) to build research capacity in China and establish long-term collaborative relationships with Vanderbilt chronic disease researchers; (4) to ensure and document the long-term success of the training programs in China that are being facilitated and upgraded through this award; (5) to build national and international leadership in chronic disease prevention and control through existing and newly established networks. The training program includes scholar training (3 months at Vanderbilt), graduate training (1-2 years of didactic course work at Fudan University, a 3-month research practicum at SIPM or SCI, and 1 year of thesis research at Vanderbilt), two five-day, in-country workshops, and an international conference. The training will focus on advanced epidemiological and biostatistical methodology, design and execution of multidisciplinary research projects, and building expertise on cancer, cardiovascular disease and diabetes research, as well as grant writing skills. The VU-Shanghai CDRTP, building upon the strength of existing research and training programs and long-standing collaborations among the participating institutes, will have a significant and long-term impact on chronic disease research and prevention in China. RELEVANCE (See instructions): Chronic disease is emerging as the leading health burden in China. Vanderbilt will partner with public health leaders in Shanghai to train cadre of experts and next generation of researchers in chronic disease research, to build the research capacity and local training facilities. This program will have significant impact on chronic disease research and prevention in China, and possibly extend to other developing countries.